References
- CF Curran, PC Blahunka, and ID Lawrence. Acute overdoses of tacrolimus. Transplantation 1996; 62 (9):1376–7.
- JJ Fung, M Alessiani, K Abu-Elmagd, S Todo, R Shapiro, A Tzakis, D Van Thiel, J Armitage, A Jain, and J McCauley. Adverse effects associated with the use of FK 506. Transplant Proc 1991; 23 (6):3105–3108.
- GL Plosker, and RH Foster. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs 2000; 59 (2):323–389.
- D Politt, B Heintz, J Floege, and PR Mertens. Tacrolimus- (FK 506) based immunosuppression in severe systemic lupus erythematosus. Clin Nephrol 2004; 62 (1):49–53.
- T Shiraga, H Matsuda, K Nagase, K Iwasaki, K Noda, H Yamazaki, T Shimada, and Y Funae. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes. Biochem Pharmacol 1994; 47 (4):727–735.
- K Nagase, K Iwasaki, K Nozaki, and K Noda. Distribution and protein binding of FK506, a potent immunosuppressive macrolide lactone, in human blood and its uptake by erythrocytes. J Pharm Pharmacol 1994; 46 (2):113–117.
- R Mrvos, M Hodgman, and EP Krenzelok. Tacrolimus (FK 506) overdose: a report of five cases. Clin Toxicol 1997; 35 (4):395–399.
- Z Karasu, A Gurakar, J Carlson, S Pennington, B Kerwin, H Wright, N Bakr, and A Sebastian. Acute tacrolimus overdose and treatment with phenytoin in liver transplant recipients. J Okla State Med Assoc 2001; 94 (4):121–123.
- CN Yeh, CH Hsieh, CM Hung, LB Jeng, TC Chao, and MF Chen. Acute overdoses of tacrolimus (FK 506). Digestive Diseases and Sciences 1999; 44 (8):1650–1652.
- LL Hardwick, and TD Batiuk. Severe prolonged tacrolimus overdose with minimal consequences. Pharmacotherapy 2002; 22 (8):1063–1066.
- S Takahashi, K Sugimoto, S Hishikawa, K Mizuta, A Fujimura, and H Kawarasaki. Recurrence of hepatic artery thrombosis following acute tacrolimus overdose in pediatric liver transplant recipient. Pediatr Transplantation 2005; 9 (6):809–12.
- JJ Fung. Tacrolimus and transplantation: a decade in review. Transplantation 2004; 77 (9 Suppl):S41–S43.
- A Hisatomi, M Kimura, M Maeda, M Matsumoto, K Ohara, and H Noguchi. Toxicity of polyoxyethylene hydrogenated castor oil 60 (HCO–60) in experimental animals. J Toxicol Sci 1993; 18 (Suppl 3):1–9.
- M Su, RS Hoffman, and LS Nelson. Acute tacrolimus overdose without significant toxicity. Clin Toxicol 2002; 40 (2):205–206.
- KE Thummel, DD Shen, TD Podoll, KL Kunze, WF Trager, CE Bacchi, CL Marsh, JP McVicar, DM Barr, JD Perkins, and RL Carithers. Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation. J Pharmacol Exp Ther 1994; 271 (1):557–566.
- I Bekersky, D Dressler, A Alak, GW Boswell, and QA Mekki. Comparative tacrolimus pharmacokinetics: normal versus mildly hepatically impaired subjects. J Clin Pharmacol 2001; 41 (6):628–635.